Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy
2012 · BMC Cancer · 23 citations
https://doi.org/10.1186/1471-2407-12-119
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
2.0K
Citations
23
h-index
32
i10-index
Marie‐Hélène Schlageter is an academic researcher from Inserm. The author has contributed to research in topics: Folate and B Vitamins Research & Biochemical and Molecular Research & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 23, co-authored 80 publications.
ORCID: 0000-0002-9507-0428Click to start Chat